GLP-1 receptor agonists (GLP-1 RAs) have spent the past few years collecting wins: glucose control, weight loss, cardiometabolic risk reduction, and no shortage of public attention.
Large Joints and Extremities Premium
GLP-1 RA Use Linked to Higher 5-Year Risk of Osteoporosis, Gout, and Osteomalacia
1 min read Premium comments

bone healthobesityosteoporosisGLP-1GLP-1 receptor agonistsemaflutidegoutosteomalaciatype-2 diabetes
React:
